Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 34 results.
User Information
Export Records
  1. 1.   Estrogen metabolism in menopausal hormone users in the Women's Health Initiative Observational Study: Does it differ between estrogen plus progestin and estrogen alone?
  2. Falk, Roni T; Manson, JoAnn E; Barnabei, Vanessa M; Anderson, Garnet L; Brinton, Louise A; Rohan, Thomas E; Cauley, Jane A; Chen, Chu; Coburn, Sally B; Pfeiffer, Ruth M; Reding, Kerryn W; Sarto, Gloria E; Wentzensen, Nicolas; Chlebowski, Rowan T; Xu, Xia; Trabert, Britton
  3. International journal of cancer. 2019, Feb 15; 144(4): 730-740.
  1. 2.   C-11-Acetate PET/CT in Localized Prostate Cancer: A Study with MRI and Histopathologic Correlation
  2. Mena, E.; Turkbey, B.; Mani, H.; Adler, S.; Valera, V. A.; Bernardol, M.; Shah, V.; Pohida, T.; McKinney, Y.; Kwarteng, G.; Daar, D.; Lindenberg, M. L.; Eclarinal, P.; Wade, R.; Linehan, W. M.; Merino, M. J.; Pinto, P. A.; Choyke, P. L.; Kurdziel, K. A.
  3. Journal of Nuclear Medicine. 2012, Apr; 53(4): 538-545.
  1. 3.   Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC
  2. Stockwin, L. H.; Yu, S. X.; Borgel, S.; Hancock, C.; Wolfe, T. L.; Phillips, L. R.; Hollingshead, M. G.; Newton, D. L.
  3. International Journal of Cancer. 2010, Dec; 127(11): 2510-2519.
  1. 4.   Molecular Modeling, Total Synthesis, and Biological Evaluations of C9-Deoxy Bryostatin 1
  2. Keck, G. E.; Poudel, Y. B.; Rudra, A.; Stephens, J. C.; Kedei, N.; Lewin, N. E.; Peach, M. L.; Blumberg, P. M.
  3. Angewandte Chemie-International Edition. 2010, Jun 21; 49(27): 4580-4584.
  1. 5.   Conformationally constrained analogues of diacylglycerol (DAG). 28. DAG-dioxolanones reveal a new additional interaction site in the C1b domain of PKC delta
  2. Choi, Y.; Pu, Y.; Peach, M. L.; Kang, J. H.; Lewin, N. E.; Sigano, D. M.; Garfield, S. H.; Blumberg, P. M.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2007, Jul; 50(15): 3465-3481.
  1. 6.   Conformationally constrained analogues of diacylglycerol (DAG). 27. Modulation of membrane translocation of protein kinase C (PKC) isozymes alpha and delta by diacylglycerol lactones (DAG-lactones) containing rigid-rod acyl groups
  2. Malolanarasimhan, K.; Kedei, N.; Sigano, D. M.; Kelley, J. A.; Lai, C. C.; Lewin, N. E.; Surawski, R. J.; Pavlyukovets, V. A.; Garfield, S. H.; Wincovitch, S.; Blumberg, P. M.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2007, Mar; 50(5): 962-978.
  1. 7.   Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms
  2. Pu, Y. M.; Peach, M. L.; Garfield, S. H.; Wincovitch, S.; Marquez, V. E.; Blumberg, P. M.
  3. Journal of Biological Chemistry. 2006, Nov; 281(44): 33773-33788.
  1. 8.   The NCI60 human tumour cell line anticancer drug screen
  2. Shoemaker, R. H.
  3. Nature Reviews Cancer. 2006, Oct; 6(10): 813-823.
  1. 9.   Critical design features of phenyl carboxylate-containing polymer microbicides
  2. Rando, R. F.; Obara, S.; Osterling, M. C.; Mankowski, M.; Miller, S. R.; Ferguson, M. L.; Krebs, F. C.; Wigdahl, B.; Labib, M.; Kokub, H.
  3. Antimicrobial Agents and Chemotherapy. 2006, Sep; 50(9): 3081-3089.
  1. 10.   Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver
  2. Liu, J.; Xie, Y. X.; Merrick, B. A.; Shen, J.; Ducharme, D. M. K.; Collins, J.; Diwan, B. A.; Logsdon, D.; Waalkes, M. P.
  3. Toxicology and Applied Pharmacology. 2006, Jun; 213(3): 216-223.
  1. 11.   Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer
  2. Palmieri, D.; Halverson, D. O.; Ouatas, T.; Horak, C. E.; Salerno, M.; Johnson, J.; Figg, W. D.; Hollingshead, M.; Hursting, S.; Berrigan, D.; Steinberg, S. M.; Merino, M. J.; Steeg, P. S.
  3. Journal of the National Cancer Institute. 2005, MAY 4; 97(9): 632-642.
  1. 12.   p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase
  2. Zhao, Y. F.; Chaiswing, L.; Velez, J. M.; Batinic-Haberle, I.; Colburn, N. H.; Oberley, T. D.; St Clair, D. K.
  3. Cancer Research. 2005, MAY 1; 65(9): 3745-3750.
  1. 13.   Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo
  2. Cataisson, C.; Pearson, A. J.; Torgerson, S.; Nedospasov, S. A.; Yuspa, S. H.
  3. Journal of Immunology. 2005, FEB 1; 174(3): 1686-1692.
  1. 14.   Minimal influence of metallothionein over-expression on nickel carcinogenesis in mice
  2. Waalkes, M. P.; Liu, J.; Kasprzak, K. S.; Diwan, B. A.
  3. Toxicology Letters. 2004, NOV 28; 153(3): 357-364.
  1. 15.   Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: Role of inclusion body formation
  2. Waalkes, M. P.; Liu, J.; Goyer, R. A.; Diwan, B. A.
  3. Cancer Research. 2004, NOV 1; 64(21): 7766-7772.
  1. 16.   Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C)
  2. Tamamura, H.; Sigano, D. M.; Lewin, N. E.; Peach, M. L.; Nicklaus, M. C.; Blumberg, P. M.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2004, SEP 23; 47(20): 4858-4864.
  1. 17.   Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis
  2. Kim, D. J.; Akiyama, T. E.; Harman, F. S.; Burns, A. M.; Shan, W. W.; Ward, J. M.; Kennett, M. J.; Gonzalez, F. J.; Peters, J. M.
  3. Journal of Biological Chemistry. 2004 279(22): 23719-23727.
  1. 18.   Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms
  2. Hou, D. X.; Kai, K.; Li, J. J.; Lin, S. G.; Terahara, N.; Wakamatsu, M.; Fujii, M.; Young, M. R.; Colburn, N.
  3. Carcinogenesis. 2004 25(1): 29-36.
  1. 19.   Saccharomyces cerevisiae phosphoenolpyruvate carboxykinase: theoretical and experimental study of the effect of glutamic acid 284 on the protonation state of lysine 213
  2. Gonzalez-Nilo, F. D.; Krautwurst, H.; Yevenes, A.; Cardemil, E.; Cachau, R.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2002 1599(1-2): 65-71.
  1. 20.   AP-1, NF kappa B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model
  2. Suzukawa, K.; Weber, T. J.; Colburn, N. H.
  3. Environmental Health Perspectives. 2002 110(9): 865-870.
  1. 21.   Toxicological consequences of differential regulation of cytochrome p450 Isoforms in rat brain regions by phenobarbital
  2. Upadhya, S. C.; Chinta, S. J.; Pai, H. V.; Boyd, M. R.; Ravindranath, V.
  3. Archives of Biochemistry and Biophysics. 2002 399(1): 56-65.
  1. 22.   Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKC alpha
  2. Garcia-Bermejo, M. L.; Leskow, F. C.; Fujii, T.; Wang, Q. M.; Blumberg, P. M.; Ohba, M.; Kuroki, T.; Han, K. C.; Lee, J.; Marquez, V. E.; Kazanietz, M. G.
  3. Journal of Biological Chemistry. 2002 277(1): 645-655.
  1. 23.   A conserved glutamate residue exhibits multifunctional catalytic roles in D-fructose-1,6-bisphosphate aldolases
  2. Maurady, A.; Zdanov, A.; de Moissac, D.; Beaudry, D.; Sygusch, J.
  3. Journal of Biological Chemistry. 2002 277(11): 9474-9483.
  1. 24.   Presence of potential nickel-responsive element(s) in the mouse MTH1 promoter
  2. Liang, R.; Igarashi, H.; Tsuzuki, T.; Nakabeppu, Y.; Sekiguchi, M.; Kasprzak, K. S.; Shiao, Y. H.
  3. Annals of Clinical and Laboratory Science. 2001 31(1): 91-98.
  1. 25.   Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation
  2. Jansen, A. P.; Colburn, N. H.; Verma, A. K.
  3. Oncogene. 1999 18(42): 5806-5813.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel